STOCK TITAN

Pacira BioSciences: DOMA reports 0% ownership

The ownership-percentage calculation uses 39,861,886 common shares outstanding as of August 3, 2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Pacira BioSciences, Inc. (PCRX) is the issuer named in a Schedule 13D amendment stating that the reporting persons ceased to be beneficial owners of more than 5% of the common shares on October 8, 2026. Each reporting-person cover page lists 0 shares and 0% beneficial ownership.

The reporting persons are DOMA Perpetual Capital Management LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation and DOMA2 LLC.

Beneficial ownership per reporting person 0 shares Listed on each reporting-person cover page
Percent of class beneficially owned per reporting person 0% Listed on each reporting-person cover page
Common shares outstanding 39,861,886 shares As of August 3, 2026; used to calculate ownership percentages
beneficially owned financial
"aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power financial
"Sole Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
dispositive power financial
"sole power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PCRX shares do the reporting persons beneficially own?

Each of the seven reporting persons is listed with 0 shares and 0% beneficial ownership of Pacira BioSciences common stock.

Who are the reporting persons in PCRX's Schedule 13D amendment?

The reporting persons are DOMA Perpetual Capital Management LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation and DOMA2 LLC. Pedro Escudero is DOMA's Chief Executive Officer and Chief Investment Officer and the sole manager of DOMA1 LLC and DOMA2 LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





695127100

(CUSIP Number)
Pedro Escudero
3350 Virginia Street, Suite 530
Miami, FL, 33133
(305) 549-5081

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/08/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Doma Perpetual Capital Management LLC
Signature:/s/ Pedro Escudero
Name/Title:Pedro Escudero/Chief Executive Officer and Chief Investment Officer
Date:10/13/2026
DOMA1 LLC
Signature:/s/ Pedro Escudero
Name/Title:Pedro Escudero/Manager
Date:10/13/2026
DOMA Perpetual LO Equity Master Fund LP
Signature:DOMA Perpetual Partners GP LLC
Name/Title:General Partner
Date:10/13/2026
Signature:/s/ Pedro Escudero
Name/Title:Pedro Escudero/Manager
Date:10/13/2026
DOMA Perpetual Partners GP LLC
Signature:/s/ Pedro Escudero
Name/Title:Pedro Escudero/Manager
Date:10/13/2026
Pedro Escudero
Signature:/s/ Pedro Escudero
Name/Title:Authorized Signatory
Date:10/13/2026
The John Templeton Foundation
Signature:/s/ Pedro Escudero
Name/Title:Authorized Signatory
Date:10/13/2026
DOMA2 LLC
Signature:/s/ Pedro Escudero
Name/Title:Pedro Escudero/Manager
Date:10/13/2026

Keep reading